NASD | Health Care | Biotechnology

Vaxart, Inc. (VXRT)

LAST (3 Apr)
0.3792
+0.0292  (+8.34%)
After-Hours (19:59:44 ET)
0.3799
+0.00  (+0.18%)
MARKET CAP
86.078 M
VOLUME
2,621,117
ENTER A SYMBOL
MEMBER ACTIONS
Summary as of: 3 Apr
Open 0.34
Previous Close 0.35
Day Range 0.34 - 0.41
52-Week Range 0.34 - 1.30
All-Time High 454.19
Avg. Volume (50-day) 1,862,780.6
EPS (TTM) -0.3483
Next Earnings Date 2025-05-08 (AMC)
Last Earnings Date 2025-03-20
Forward Annual Dividend (Yield) -
Trailing Annual Dividend (Yield) -
Options Yes
Fundamentals
P/E Ratio -1.0000
PEG Ratio -
Price to Book 1.35
Price to Cash Flow -
Price to Free Cash Flow -
Total Sales (TTM) 28.70 M
Revenue per Share (TTM) 0.13
Shares Outstanding 227.949 M
Share Float (%) 222.31 M (97.53%)
% Held by Institutions 22.55
Dividends Per Share (TTM) -
Ex-Dividend Date -
Technicals
+/- EMA(20) 0.47 (-19.32%)
+/- SMA(50) 0.59 (-35.73%)
+/- SMA(200) 0.7 (-45.83%)
5-Day Perf. -17.02%
1-Month Perf. -19.7%
3-Month Perf. -54.72%
6-Month Perf. -53.82%
YTD Perf. -42.73%
1-Year Perf. -69.17%
RSI(14) 31.93
ATR(14) 0.05
ADX(14) 30.51
Beta (5Y) 1.37
Earnings NEW

FOR STOCKCHARTS MEMBERS ONLY

Unlock earnings and revenue history when you join StockCharts

As a StockCharts Member, you can review earnings results and analyze revenue and earnings growth over time. Bring a balance of technicals and fundamentals to your approach when you join today!

SCTR Rank SCTR Reports  

VXRT

13.7
(+3.9)
SCTR Universe: Small Cap
Click Here for more info about the StockCharts Technical Rankings (SCTRs)
Profile

Vaxart, Inc.

170 Harbor Way, Suite 300
South San Francisco, California
http://www.vaxart.com
Sector: Health Care
Industry: Biotechnology
Employees: 115
Description

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded by Sean Tucker in March 2004 and is headquartered in South San Francisco, CA.

Alerts for VXRT View All   New

FOR STOCKCHARTS MEMBERS ONLY

Unlock custom technical alerts when you join StockCharts

As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.

ChartLists with VXRT

FOR STOCKCHARTS MEMBERS ONLY

Unlock ChartLists to save and organize your charts when you join StockCharts

As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.